Research News
 

Thursday, July 30, 2009
The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization

C. Patrick Carroll (1), Carlton Haywood Jr. (2 3), Peter Fagan (1 4), Sophie Lanzkron (2) American Journal of Hematology  
1Department of Psychiatry Behavioral Sciences, The Johns Hopkins School of Medicine
2Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine
3The Johns Hopkins Berman Institute of Bioethics
4Johns Hopkins Healthcare, LLC

ABSTRACT
Although most patients with sickle cell disease (SCD) are hospitalized infrequently and manage painful crises at home, a small subpopulation is frequently admitted to emergency departments and inpatient units. This small group accounts for the majority of health care expenses for patients with SCD. Using inpatient claims data from a large, urban Medicaid MCO for 5 consecutive years, this study sought to describe the course of high inpatient utilization (averaging four or more admissions enrolled per year for at least 1 year) in members with a diagnosis of SCD and a history of hospitalizations for vaso-occlusive crisis. High utilizers were compared with the other members with SCD on demographics, medical and psychiatric comorbidity, and use of other health care resources. Members who were high utilizers had more diagnostic mentions of sickle cell complications than low utilizers. However, the pattern of high inpatient utilization was likely to moderate over successive years, and return to the pattern after moderation was uncommon. Despite this, a small subpopulation engaged in exceptional levels of inpatient utilization over multiple years. 
Back  Email this Press Release Print View All Press Releases